Improving Our Understanding of Respiratory Muscle Training to Facilitate Weaning From Mechanical Ventilation in the ICU
Launched by KU LEUVEN · Dec 1, 2020
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of respiratory muscle training can help patients who are having trouble coming off mechanical ventilation in the ICU. Mechanical ventilation is a machine that helps patients breathe when they are too weak to do it on their own, but it can sometimes cause weakness in the muscles that control breathing. This trial aims to understand how these muscles respond to various training methods during the weaning process, which is the time when patients are gradually taken off the ventilator.
To participate in this study, patients need to be between the ages of 65 and 74 and have had difficulty coming off mechanical ventilation. They should be stable in their health, meaning their temperature and blood pressure are normal, and they don't have serious heart issues or other significant health problems. Participants will be monitored while they try different training approaches that may help strengthen their breathing muscles. This research is important because it could lead to better ways to help patients recover from mechanical ventilation and improve their chances of survival in the ICU.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Difficult and prolonged weaning patients
- • Adequate oxygenation
- • Febrile temperature \< 38ºC
- • Hemodynamic stability
- • Stable blood pressure
- • No or minimal vasopressors
- • No myocardial ischemia
- • Adequate hemoglobin and mentation
- • Resolution of disease acute phase
- • Able to follow simple verbal commands related to IMT
- • Mechanically ventilated via a tracheostomy or endotracheal tube
- Exclusion Criteria:
- • Pre-existing neuromuscular disease
- • Agitation
- • Hemodynamically instable (arrhythmia, decompensated heart failure, coronary insufficiency)
- • Hemoptysis
- • Diaphoresis
- • Spinal cord injury above T8
- • Use of any type of home MV support prior to hospitalization
- • Skeletal pathology that impairs chest wall movements
- • Poor general prognosis or fatal outcome
About Ku Leuven
KU Leuven, a prestigious research university located in Belgium, is renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, KU Leuven integrates cutting-edge research with clinical practice, facilitating the development of new therapeutic strategies and medical technologies. The institution's robust infrastructure and expertise in various fields, including biotechnology, pharmacology, and public health, position it as a leader in conducting high-quality clinical research that adheres to rigorous ethical standards and regulatory requirements. Through its clinical trials, KU Leuven aims to contribute significantly to the global biomedical landscape and enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials